Ranking buffel: Comparative risk and mitigation costs of key environmental and socio‐cultural threats in central Australia
Sign Up to like & getrecommendations! Published in 2020 at "Ecology and Evolution"
DOI: 10.1002/ece3.6724
Abstract: Abstract Changed fire regimes and the introduction of rabbits, cats, foxes, and large exotic herbivores have driven widespread ecological catastrophe in Australian arid and semi‐arid zones, which encompass over two‐thirds of the continent. These threats… read more here.
Keywords: risk mitigation; buffel comparative; buffel; ranking buffel ... See more keywords
Comparative risk assessment with focus on hydrogen and selected fuel cells: Application to Europe
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Hydrogen Energy"
DOI: 10.1016/j.ijhydene.2018.04.004
Abstract: Abstract In this study, a first-of-its-kind comparative risk assessment is presented for accidents in the energy sector in EU28 with focus on hydrogen (H2) and selected fuel cells, namely proton exchange membrane (PEM), phosphoric acid… read more here.
Keywords: fuel cells; risk assessment; selected fuel; fuel ... See more keywords
Comparative Risk Assessment of spill response options for a deepwater oil well blowout: Part 1. Oil spill modeling.
Sign Up to like & getrecommendations! Published in 2018 at "Marine pollution bulletin"
DOI: 10.1016/j.marpolbul.2018.05.042
Abstract: Oil spill model simulations of a deepwater blowout in the Gulf of Mexico De Soto Canyon, assuming no intervention and various response options (i.e., subsea dispersant injection SSDI, in addition to mechanical recovery, in-situ burning,… read more here.
Keywords: spill; oil spill; response options; comparative risk ... See more keywords
The Comparative Risk of Serious Adverse Events With Tofacitinib and TNF Inhibitors in Patients With Ulcerative Colitis: The Korean Experience as Revealed by a National Database
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Korean Medical Science"
DOI: 10.3346/jkms.2022.37.e123
Abstract: Tofacitinib is an oral, small-molecule Janus kinase inhibitor approved in South Korea for the treatment of moderate to severe ulcerative colitis (UC) on May 1, 2019. However, safety data are lacking. We investigated the incidence… read more here.
Keywords: risk serious; events tofacitinib; serious adverse; comparative risk ... See more keywords